MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 4.55 HKD 1.11% Market Closed
Market Cap: 1.9B HKD
Have any thoughts about
MicroTech Medical Hangzhou Co Ltd?
Write Note

MicroTech Medical Hangzhou Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MicroTech Medical Hangzhou Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Total Liabilities & Equity
ÂĄ2.2B
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Liabilities & Equity
ÂĄ2.6B
CAGR 3-Years
63%
CAGR 5-Years
51%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Liabilities & Equity
ÂĄ15.6B
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Liabilities & Equity
ÂĄ60.6B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Liabilities & Equity
ÂĄ5.5B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Liabilities & Equity
ÂĄ25.3B
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
1.9B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
5.84 HKD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
2.2B CNY

Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Total Liabilities & Equity amounts to 2.2B CNY.

What is MicroTech Medical Hangzhou Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
41%

Over the last year, the Total Liabilities & Equity growth was -6%. The average annual Total Liabilities & Equity growth rates for MicroTech Medical Hangzhou Co Ltd have been 41% over the past three years .

Back to Top